Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
Its literally life or death, Lopez said
For a peer-reviewed look at why the peptide attracts so much interest, this review of BPC-157s cytoprotective and healing effects across multiple tissue systems published in Current Pharmaceutical Design summarizes the preclinical evidence base behind the recovery claims
A 2024 Swedish study followed 3,249 MS patients for an average of 10.6 years and found that obesity was associated with: 4 43% higher risk of reaching EDSS 3 (moderate disability) 40% higher risk of reaching EDSS 4 (significant walking impairment) More rapid cognitive decline Higher MRI activity showing new brain lesions A German study of 1,066 MS patients found that obese patients reached disability milestones more quickly than those with normal weight
Each shows the exact mistake, the measurable consequence, and the fix
